Common Equity: The sum of all common equity items.
ACADIA Pharmaceuticals Inc. (ACAD) had Common Equity of $732.79M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$957.80M |
|
$226.45M |
|
$81.84M |
|
$875.96M |
|
$727.00M |
|
$230.79M |
|
$27.28M |
|
$258.07M |
|
$258.07M |
|
$226.45M |
|
$226.45M |
|
$226.45M |
|
$226.45M |
|
$230.79M |
|
$237.37M |
|
165.72M |
|
166.36M |
|
$1.37 |
|
$1.36 |
|
| Balance Sheet Financials | |
$938.32M |
|
$4.21M |
|
$249.44M |
|
$1.19B |
|
$394.87M |
|
-- |
|
$60.09M |
|
$454.96M |
|
|
Common Equity |
$732.79M |
$613.01M |
|
$732.79M |
|
166.71M |
|
| Cash Flow Statement Financials | |
$157.72M |
|
$-30.54M |
|
$6.84M |
|
$194.43M |
|
$328.36M |
|
$133.93M |
|
$67.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
91.46% |
|
24.10% |
|
24.10% |
|
24.78% |
|
26.94% |
|
23.64% |
|
$157.20M |
|
-- |
|
-- |
|
-- |
|
0.81 |
|
3.73 |
|
9.15 |
|
39.90 |
|
30.90% |
|
36.94% |
|
19.07% |
|
30.90% |
|
$4.40 |
|
$0.94 |
|
$0.95 |
|